Literature DB >> 28306326

Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.

Elena Tejero1, Eva Prats2, Raquel Casitas3,4,5, Raúl Galera3,4,5, Paloma Pardo1, Adelaida Gavilán2, Elisabet Martínez-Cerón3,4,5, Carolina Cubillos-Zapata4,5, Luis Del Peso4,5,6,7, Francisco García-Río3,4,5,8.   

Abstract

RATIONALE: Global Lung Function Initiative recommends reporting lung function measures as z-score, and a classification of airflow limitation (AL) based on this parameter has recently been proposed.
OBJECTIVES: To evaluate the prognostic capacity of the AL classifications based on z-score or percentage predicted of FEV1 in patients with chronic obstructive pulmonary disease (COPD).
METHODS: A cohort of 2,614 patients with COPD recruited outside the hospital setting was examined after a mean (± SD) of 57 ± 13 months of follow-up, totaling 10,322 person-years. All-cause mortality was analyzed, evaluating the predictive capacity of several AL staging systems.
MEASUREMENTS AND MAIN RESULTS: Based on Global Initiative for Chronic Obstructive Lung Disease guidelines, 461 patients (17.6%) had mild, 1,452 (55.5%) moderate, 590 (22.6%) severe, and 111 (4.2%) very severe AL. According to z-score classification, 66.3% of patients remained with the same severity, whereas 23.7% worsened and 10.0% improved. Unlike other staging systems, patients with severe AL according to z-score had higher mortality than those with very severe AL (increase of risk by 5.2 and 3.9 times compared with mild AL, respectively). The predictive capacity for 5-year survival was slightly higher for FEV1 expressed as percentage of predicted than as z-score (area under the curve: 0.714-0.760 vs. 0.649-0.708, respectively). A severity-dependent relationship between AL grades by z-score and mortality was only detected in patients younger than age 60 years.
CONCLUSIONS: In patients with COPD, the AL classification based on z-score predicts worse mortality than those based on percentage of predicted. It is possible that the z-score underestimates AL severity in patients older than 60 years of age with severe functional impairment.

Entities:  

Keywords:  airflow limitation; chronic obstructive pulmonary disease; mortality; spirometry; staging

Mesh:

Year:  2017        PMID: 28306326     DOI: 10.1164/rccm.201611-2265OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Update in Chronic Obstructive Pulmonary Disease 2017.

Authors:  William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

2.  Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  COPD       Date:  2018-02       Impact factor: 2.409

3.  Associations Between Physical Activity, Smoking Status, and Airflow Obstruction and Self-Reported COPD: A Population-Based Study.

Authors:  Yao-Kuang Wu; Wen-Lin Su; Mei-Chen Yang; Sin-Yi Chen; Chih-Wei Wu; Chou-Chin Lan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-05-20

4.  COPD in exclusive narghile smokers: Some points to verify.

Authors:  Helmi Ben Saad
Journal:  Chron Respir Dis       Date:  2017-11       Impact factor: 3.115

5.  Authors' response to letter-COPD in exclusive narghile smokers: Some points to verify.

Authors:  Mehrzad Bahtouee; Nasrollah Maleki; Fatemeh Nekouee
Journal:  Chron Respir Dis       Date:  2017-10-02       Impact factor: 2.444

6.  Defining and grading an obstructive ventilatory defect (OVD): 'FEV1/FVC lower limit of normal (LLN) vs. Z-score' and 'FEV1 percentage predicted (%pred) vs. Z-score'.

Authors:  Rim Kammoun; Ines Ghannouchi; Sonia Rouatbi; Helmi Ben Saad
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.743

7.  Undiagnosed and Misdiagnosed Chronic Obstructive Pulmonary Disease: Data from the BOLD Australia Study.

Authors:  Kate Petrie; Brett G Toelle; Richard Wood-Baker; Graeme P Maguire; Alan L James; Michael Hunter; David P Johns; Guy B Marks; Johnson George; Michael J Abramson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.